substance p has been researched along with Cholangiocellular Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afroze, S; Alpini, G; Avila, S; DeMorrow, S; Frampton, G; Francis, H; Glaser, S; Guerrier, M; Han, Y; Hargrove, L; Kennedy, L; McDaniel, K; McMillin, M; Meng, F; Quezada, M; Ray, D; Standeford, H; Venter, J | 1 |
1 other study(ies) available for substance p and Cholangiocellular Carcinoma
| Article | Year |
|---|---|
Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth.
Topics: Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Keratin-19; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neprilysin; Neurokinin-1 Receptor Antagonists; Proliferating Cell Nuclear Antigen; Receptors, Neurokinin-1; Substance P; Time Factors; Transfection; Tumor Burden; Up-Regulation; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2014 |